Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 1 hour 52 min ago

Kisqali success continues with positive late-stage trial results

The success marks the second Phase III clinical trial in which Kisqali met overall survival.

Nubeqa bags FDA green light

The drug has been approved under the governing body’s Priority Review designation.

Eli Lilly announces Verzenio survival benefit

Breast cancer is the most common cancer in women worldwide, with more than two million new cases diagnosed in 2018.

Neuraxpharm launches first products in UK

It has also announced the appointment of the company’s new general manager, Craig Bowen.

Biodesix, Immodulon team up for pancreatic cancer treatment

The partnership will focus on the analysis of the circulating proteome of advanced pancreatic cancer patients treated with IMM-10.

RCGP warns new PM that we ‘cannot risk no-deal disruption’

Johnson also took a moment in his speech to announced that he wants to revisit and potentially reverse the sugar tax.

52 cases of malaria reported in Scotland

The figure is an increase of 4% from the 2017 total.

IONTAS, Teva announce new antibody optimisation agreement

Teva recently halted its Ajovy clinical development.

EMA positive opinion granted for Keytruda combo

The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorisation.

NICE expands draft recommendation for Lokelma

The news comes shortly after AZ announced positive results from a late-stage trial of the drug.

Finals day location confirmed for the 2019 Marketer of the year competition

IQVIA have been confirmed to host the finals days for the 2019 PharmaTimes Marketer of the Year and also the Sales Awards at their offices in Reading.

£3m funding for MS, Parkinson’s

The money will go to a new UK ‘digital brain bank’, Europe’s largest brain and tissue bank, based in London.

AZ presents strong H1 financial results

The sales numbers were boosted by oncology drugs such as Tagrisso, Imfinzi and Lynparza.

Janssen’s ponesimod holds up against Aubagio in late-stage trial

The drug is a selective sphingosine-1-phosphate receptor 1 (S1P1) modulator.

First convergent science centre launched in UK

Scientists are “re-imagining ultrasound technology to develop a treatment that can liquefy cancer cells in the body using microscopic bubbles”.

ViiV submits regulatory application to EMA for investigational HIV combo

The application is for cabotegravir and Edurant (rilpivirine) as the first monthly, injectable treatment for HIV.

Skin cancer rates rocket 45% in 10 years

Rates have increased by more than a third (35%) for women and by almost three-fifths (55%) for men.

NHS Confederation responds to PM’s promise to ‘fix crisis’

But the organisation says it will “need more details of exactly how this will be achieved".

FDA accepts Brinavess resubmission

The FDA initially cited insufficient data and refused to accept the initial submission in August 2017.

New inquiry into healthy ageing launched

Increasing health span has been adopted as a policy objective by the UK Government in the Industrial Strategy’s “Ageing Society”.